Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)

Status unconfirmed · Phase 4

Conditions studied: Anticoagulation, Anticoagulation Reversal

In brief

Prospective assessment of vitamin K dependent coagulation factor levels after temporary warfarin reversal in participants with left ventricular assist devices (LAVD).

Key facts

Study ID

NCT03473132

Run by

Brigham and Women's Hospital

People needed

50

Starts

2018-03-15

Expected to finish

2022-03-31

Last updated by the study team

2021-05-05

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• LVAD on warfarin requiring temporary interruption of anticoagulation for procedures

You may not qualify if…

• recent thrombotic event

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.